5European Best Practice Guudelines For Renal Transplantaion, Section Ⅳ. Long - term management of the transplant recipient Ⅳ. 2. 6. Chronic graft dysfunction, Late recurrence of other diseases. Nephrol Dial Transplant,2002,17 ( auppl 4) :18 - 19.
6Zou H, Shi Y, Chen L, et al. Expression and Role of matrix metalloproteinases/tissue inhibitors of metalloproteinases at the early stage of chronic allograft nephropathy (CAN). J Transplant Medicine,2007,2 (2):81 -90.
7Zou H, Wang G, Yao J, et al. Expression and significance of MCP - 1 and RANTES in renal tissue with chronic allograft nephropathy. J Transplant Medicine ,2007,2(3) : 143 - 150.
8邹和群.慢性移植肾病[J].器官移植内科学杂志,2007,2:32-40.
9Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA ,2001,285 (19) :2486.
10Busija DW, miller AW, Katakam P, et al. Mechanisms of vascular dysfunction in insulin resistance. Curr Opin Investig Drugs, 2004,5: 929 - 935.
